FDA’s Trigger Policy For Generic Lawsuit Decisions “Facilitates Certainty,” Court Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
The decision will uphold FDA’s newly created policy, barring a dissenting opinion from the District Court of Appeals.